Cutaneous lupus erythematosus: clinical features, prognosis and laboratory findings

References

• Talbot JH. Historical background of discoid and systemic lupus erythematosus. In: Dubois’ Lupus Erythematosus (4th Edition). Wallace DJ, Hahn BH (Eds). Lea and Fiebiger, Philadelphia, PA, USA, 3–12 (1993).
   Google Scholar
• Wallace DJ. Management of lupus erythematosus: recent insights. Curr. Opin. Rheumatol.14, 212–219 (2002).
   PubMedGoogle Scholar
• Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas. J. Dermatol.47, 13–27 (2006).
   PubMed Web of Science ®Google Scholar
• Sontheimer RD, Provost TT. Lupus erythematosus. In: Cutaneous Manifestations of Rheumatic Diseases. Sontheimer RD, Provost TT (Eds). William & Wilkins, Baltimore, MO, USA, 1–71 (1996).
   Google Scholar
• Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.25, 1271–1277 (1982).
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology190, 277–283 (1996).
   Google Scholar
• McCauliffe DP. Cutaneous lupus erythematosus. Semin. Cutan. Med. Surg.20, 14–26 (2001).
   PubMedGoogle Scholar
• Zecevic RD, Vojvodvic D, Ristic B, Pavlovic MD, Stefanovic D, Karadaglic D. Skin lesion – an indicator of disease activity in systemic lupus erythematosus? Lupus10, 364–367 (2001).
   PubMed Web of Science ®Google Scholar
• Patel PP, Werth V. Cutaneous lupus erythematosus: a review. Dermatol. Clin.20, 373–385 (2002).
   PubMed Web of Science ®Google Scholar
• Sticherling M. Chronic cutaneous lupus erythematosus. In: Autoimmune Disease of the Skin – Pathogenesis, Diagnosis, Management. Hertl M (Ed.). Springer Wien, NY, USA, 337–364 (2005).
   Google Scholar
• Wysenbeek AJ, Leibovici L, Amit M, Weinberger A. Alopecia in systemic lupus erythematosus. Relation to disease manifestations. J. Rheumatol.18, 1185–1186 (1991).
   PubMedGoogle Scholar
• Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br. J. Dermatol.121, 727–741 (1989).
   PubMed Web of Science ®Google Scholar
• Marks R. Lichen planus and cutaneous lupus erythematosus. In: Retinoids. A Clinician’s Guide. Lowe N, Marks R (Eds). Martin Dunitz, London, UK, 113–117 (1995).
   Google Scholar
• Botella R, Alfonso R, Silvestre JF, Ramon R. Discoid lupus erythematosus-like lesions and stomatitis. Arch. Dermatol.135, 847–850 (1999).
   PubMedGoogle Scholar
• Perniciaro C, Randle HW, Perry HO. Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol. Surg.21, 255–257 (1995).
   PubMedGoogle Scholar
• Uy HS, Pineda R 2nd, Shore JW, Polcharoen W, Jakobiec FA, Foster CS. Hypertrophic discoid lupus erythematosus of the conjunctiva. Am. J. Ophthalmol.127, 604–605 (1999).
   PubMedGoogle Scholar
• Dabski K, Stoll H, Milgrom H. Squamous cell carcinoma complicating late chronic discoid lupus erythematosus. J. Surg. Oncol.32, 233–237 (1986).
   PubMedGoogle Scholar
• Millard LG, Barker DJ. Development of squamous cell carcinoma in chronic discoid lupus erythematosus. Clin. Exp. Dermatol.3, 161–166 (1978).
   PubMedGoogle Scholar
• Caproni M, Palleschi GM, Papi C, Fabbri P. Discoid lupus erythematosus lesions developed on lupus erythematosus profundus nodules. Int. J. Dermatol.34, 357–359 (1995).
   PubMedGoogle Scholar
• Watanabe T, Tsuchida T. Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br. J. Dermatol.134, 123–125 (1996).
   PubMedGoogle Scholar
• Kundig TM, Trueb RM, Krasovec M. Lupus profundus/panniculitis. Dermatology195, 99–101 (1997).
   PubMedGoogle Scholar
• Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J. Rheumatol.26, 68–72 (1999).
   PubMedGoogle Scholar
• Su WP, Perniciaro C, Rogers RS 3rd, White JW Jr. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis54, 395–399 (1994).
   PubMedGoogle Scholar
• Fisher DA, Everett MA. Violaceous rash of dorsal fingers in a woman. Diagnosis: chilblain lupus erythematosus (perniosis). Arch. Dermatol.132, 459–462 (1996).
   PubMedGoogle Scholar
• Dekle CL, Mannes KD, Davis LS, Sangueza OP. Lupus tumidus. J. Am. Acad. Dermatol.41, 250–253 (1999).
   PubMedGoogle Scholar
• Ruiz H, Sanchez JL. Tumid lupus erythematosus. Am. J. Dermatopathol.21, 356–360 (1999).
   PubMedGoogle Scholar
• Rupec RA, Petropoulou T, Belohradsky BH, Walchner M, Liese JG, Plewig G. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur. J. Dermatol.10, 184–189 (2000).
   PubMedGoogle Scholar
• Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J. Am. Acad. Dermatol.48, 901–908 (2003).
   PubMedGoogle Scholar
• Kanda N, Tsuchida T, Watanabe T, Tamaki K. Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis. J. Cutan. Pathol.24, 553–558 (1997).
   PubMed Web of Science ®Google Scholar
• Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A. Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology206, 326–329 (2003).
   PubMedGoogle Scholar
• Williams WL, Ramos-Caro FA. Acute periorbital mucinosis in discoid lupus erythematosus. J. Am. Acad. Dermatol.41, 871–873 (1999).
   PubMedGoogle Scholar
• Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K. Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J. Am. Acad. Dermatol.36, 214–218 (1997).
   PubMedGoogle Scholar
• Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus. Arch. Dermatol.115, 1409–1415 (1979).
   PubMed Web of Science ®Google Scholar
• Callen JP. Is subacute cutaneous lupus erythematosus a subset of systemic lupus erythematosus or a distinct entity? Br. J. Dermatol.144, 450 (2001).
   PubMedGoogle Scholar
• Black DR, Hornung CA, Schneider PD, Callen JP. Frequency and severitiy of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch. Dermatol.138, 1175–1178 (2002).
   PubMedGoogle Scholar
• McCauliffe DP. Distinguishing subacute cutaneous from other types of lupus erythematosus. Lancet351, 1527–1528 (1998).
   PubMedGoogle Scholar
• Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J. Am. Acad. Dermatol.22, 181–187 (1990).
   PubMed Web of Science ®Google Scholar
• Kind P, Lehmann P, Plewig G. Phototesting in lupus erythematosus. J. Invest. Dermatol.100, S53–S57 (1993).
   PubMedGoogle Scholar
• Hasan T, Nyberg F, Stephansson E et al. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br. J. Dermatol.136, 699–705 (1997).
   PubMedGoogle Scholar
• Kuhn A, Sonntag M, Richter-Hintz D et al. Phototesting in lupus erythematosus: a 15-year experience. J. Am. Acad. Dermatol.45, 86–95 (2001).
   PubMed Web of Science ®Google Scholar
• Nyberg F, Hasan T, Puska P et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br. J. Dermatol.136, 217–221 (1997).
   PubMedGoogle Scholar
• Millard TP, Kondeatis E, Vaughan RW et al. Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus10, 473–479 (2001).
   PubMedGoogle Scholar
• Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognised. J. Am. Acad. Dermatol.45, 315–316 (2001).
   PubMed Web of Science ®Google Scholar
• Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH. Etanerecept-induced subacute cutaneous lupus erythematosus. Rheumatology40, 1317–1319 (2001).
   PubMed Web of Science ®Google Scholar
• Bentley DD, Graves JE, Smith DI, Heffernan MP. Efalizumab-induced subacute cutaneous lupus erythematosus. Am. Acad. Dermatol.54, S242–S243 (2006).
   Google Scholar
• Bonsmann G, Schiller M, Luger TA, Ständer S. Terbinafine-induced subacute cutaneous lupus erythematosus. J. Am. Acad. Dermatol.44, 925–931 (2001).
   PubMed Web of Science ®Google Scholar
• Yell JA, Burge SM. The effect of hormonal changes on cutaneous disease in lupus erythematosus. Br. J. Dermatol.129, 18–22 (1993).
   PubMed Web of Science ®Google Scholar
• Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann. NY Acad. Sci.840, 45–50 (1998).
   PubMed Web of Science ®Google Scholar
• Meier CR, Sturkenboom MCJM, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J. Rheumatol.25, 1515–1519 (1998).
   PubMed Web of Science ®Google Scholar
• Petri M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. N. Eng. J. Med.353, 2550–2558 (2005).
   PubMed Web of Science ®Google Scholar
• Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N. Eng. J. Med.353, 2539–2549 (2005).
   PubMed Web of Science ®Google Scholar
• Kanda N, Tsuchida T, Watanabe T, Tamaki K. Clinical features of systemic lupus erythematosus in men. Characteristics of the cutaneous manifestations. Dermatology193, 6–10 (1996).
   PubMedGoogle Scholar
• Gladman DD, Urowitz MB. Systemic lupus erythematosus: clinical features. In: Rheumatology (2nd Edition). Klippel JH, Dieppe PA (Eds). Mosby, St. Louis, MO, USA (1998).
   Google Scholar
• Urowitz MB, Gladman DD. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology39, 238–244 (2000).
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Veller-Fornasa C, Patrassi GM, Sartori E, Tonello M, Tonetto S. Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus. Clin. Rheumatol.14, 402–404 (1995).
   PubMedGoogle Scholar
• Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J. Pediatr.137, 674–680 (2000).
   PubMedGoogle Scholar
• George PM, Tunnessen WW Jr. Childhood discoid lupus erythematosus. Arch. Dermatol.129, 613–617 (1993).
   PubMedGoogle Scholar
• Lee LA, Weston WL. Cutaneous lupus erytheamatosus during the neonatal and childhood periods. Lupus6, 132–138 (1997).
   PubMedGoogle Scholar
• Wananukul S, Satana D, Pongprasit P. Cutaneous manifestation of childhood systemic lupus erythematosus. Pediatr. Dermatol.15, 342–346 (1998).
   PubMedGoogle Scholar
• Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus9, 96–100 (2000).
   PubMed Web of Science ®Google Scholar
• Fumal I, Danchin A, Cosserat F, Barbaud A, Schmutz JL. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases. Dermatology210, 251–251 (2005).
   PubMed Web of Science ®Google Scholar
• Norris DA, Bennion SD, David-Bajar K. Pathomechanisms of cutaneous lupus erythematosus. In: Dubois’ Lupus Erythematosus (4th Edition). Wallace DJ, Hahn BH (Eds). Lea and Fiebiger, Philadelphia, PA, USA, 549–567 (1996).
   Google Scholar
• Bielsa I, Herrero C, Ercilla G et al. Immunogenetic findings in cutaneous erythematosus. J. Am. Acad. Dermatol.25, 251–257 (1991).
   PubMedGoogle Scholar
• Millard TP, McGregor JM. Molecular genetics of cutaneous lupus erythematosus. Clin. Exp. Dermatol.26, 184–191 (2001).
   PubMed Web of Science ®Google Scholar
• Asghar SS, Venneker GT, van Meegen M, Meinardi MM, Hulsmans RF, de Waal LP. Hereditary deficiency of C5 in association with discoid lupus erythematosus. J. Am. Acad. Dermatol.24, 376–378 (1991).
   PubMedGoogle Scholar
• Sullivan KE. Complement deficiency and autoimmunity. Curr. Opin. Pediatr.10, 600–606 (1998).
   PubMedGoogle Scholar
• Racila DM, Sontheimer CJ, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD. Homozygous single nucleotide polmorphism oof the complement C1QA gene is associated with decreased levels of C1q in patients with subcute cataneous lupus erythematosus. Lupus12, 124–132 (2003).
   PubMedGoogle Scholar
• Nousari HC, Kimyai-Asadi A, Provost TT. Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4. J. Am. Acad. Dermatol.41, 362–364 (1999).
   PubMedGoogle Scholar
• Lipsker DM, Schreckenberg-Giliot C, Uring-Lambert B et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch. Dermatol.136, 1508–1514 (2000).
   PubMedGoogle Scholar
• Werth VP, ZhangW, Dortzbach K, Sullivan K. Association of a promoter polymorphism of tumour necrosis factor-α (TNF-α) with subacute cutaneous lupus erythematosus. J. Invest. Dermatol.115, 726–730 (2000).
   PubMedGoogle Scholar
• Gallego H, Crutchfield CE 3rd, Lewis EJ, Gallego HJ. Report of an association between discoid lupus erythematosus and smoking. Cutis63, 231–234 (1999).
   PubMedGoogle Scholar
• Orteu DH, Sontheimer RD, Dutz JP. The pathopysiology of photosensitivity in lupus erythematosus. Photodermatol. Photoimmunol. Photomed.17, 95–113 (2001).
   PubMedGoogle Scholar
• Baima B, Sticherling M. Apoptosis in different manifestations of cutaneous lupus erythematosus. Br. J. Dermatol.144, 958–966 (2001).
   PubMed Web of Science ®Google Scholar
• Casiano C, Wu X, Molinaro C. Apoptosis, necrosis, and the genesis of antinuclear antibodies. Autoantigens and autoantibodies: diagnostic tool and clues to understanding autoimmunity. Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (Eds). Pabst Science Publishers, Lengerich, Germany, 152–186 (2000).
   Google Scholar
• Golan TD, Sigal D, Sabo E, Shemuel Z, Guedj D, Weinberger A. The penetrating potential of autoantibodies into live cells in vitro coincides with the in vivo staining of epidermal nuclei. Lupus6, 18–26 (1997).
   PubMedGoogle Scholar
• Provost TT, Watson R, Simmons-O’Brien E. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J. Am. Acad. Dermatol.35, 147–169 (1996).
   PubMedGoogle Scholar
• Mond CB, Peterson MG, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum.32, 202–204 (1989).
   PubMed Web of Science ®Google Scholar
• Kuhn A, Herrmann M, Kleber S et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum.54, 939–950 (2006).
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med.179, 1317–1330 (1994).
   PubMed Web of Science ®Google Scholar
• Tan EM. Autoimmunity and apoptosis. J. Exp. Med.179, 1083–1086 (1994).
   PubMedGoogle Scholar
• Sontheimer RD, Bergstresser PR. Epidermal Langerhans cell involvement in cutaneous lupus erythematosus. J. Invest. Dermatol.79, 237–243 (1982).
   PubMed Web of Science ®Google Scholar
• Denfeld RW, Kind P, Sontheimer RD, Schöpf E, Simon JC. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum.40, 814–821 (1997).
   PubMedGoogle Scholar
• Janssens AS, Lashley EE, Out-Luiting CJ, Willemze R, Pavel S, de Gruijl FR. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells. Exp. Dermatol.14, 138–142 (2005).
   PubMed Web of Science ®Google Scholar
• Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J. Am. Acad. Dermatol.36, 191–196 (1997).
   PubMedGoogle Scholar
• Volc-Platzer B, Anegg B, Milota S, Pickl W, Fischer G. Accumulation of γ δ T cells in chronic cutaneous lupus erythematosus. J. Invest. Dermatol.100, S84–S91 (1993).
   Google Scholar
• Furukawa F, Tokura Y, Matsushita K et al. Selective expansions of T cells expressing V β 8 and V β 13 in skin lesions of patients with chronic cutaneous lupus erythematosus. J. Dermatol.23, 670–676 (1996).
   PubMedGoogle Scholar
• Hasan T, Stephansson E, Ranki A. Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm. Venereol.79, 437–442 (1999).
   PubMedGoogle Scholar
• Jacob CO. Tumor necrosis factor and interferon gamma: relevance for immune regulation and genetic predisposition to autoimmune disease. Semin. Immunol.4, 147–154 (1992).
   PubMedGoogle Scholar
• Middleton MH, Norris DA. Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J. Invest. Dermatol.104, 489–496 (1995).
   PubMedGoogle Scholar
• Kuhn A, Sonntag M, Lehmann P, Megahed M, Vestweber D, Ruzicka T. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus. Arch. Dermatol. Res.294, 6–13 (2002).
   PubMedGoogle Scholar
• Wenzel J, Henze S, Worenkamper E et al. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus. J. Invest. Dermatol.124, 1241–1248 (2005).
   PubMedGoogle Scholar
• Popovic K, Ek M, Espinosa A et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum.52, 3639–3645 (2005).
   PubMed Web of Science ®Google Scholar
• de Jong EM, van der Vleuten CJ, van Vlijmen-Willems IM. Differences in extracellular matrix proteins, epidermal growth and differentiation in discoid lupus erythematosus, lichen planus and the overlap syndrome. Acta. Derm. Venereol.77, 356–360 (1997).
   PubMedGoogle Scholar
• Parodi A, Rebora A. ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus. Dermatology194, 217–220 (1997).
   PubMedGoogle Scholar
• Parodi A, Massone C, Cacciapuoti M et al. Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br. J. Dermatol.142, 457–460 (2000).
   PubMed Web of Science ®Google Scholar
• Tebbe B, Mansmann U, Wollina U et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta. Derm. Venereol.77, 305–308 (1997).
   PubMed Web of Science ®Google Scholar
• Albrecht J, Taylor L, Berlin JA et al. The CLASI (cutaneous lupus erythematosus disease area and severity index): an outcome instrument for cutaneous lupus erythematosus. J. Invest. Dermatol.125, 889–894 (2005).
   PubMed Web of Science ®Google Scholar
• Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin. Dermatol.22, 121–124 (2004).
   PubMedGoogle Scholar
• Bernatsky S, Clarke A, Abrahamowicz M, Neville C, Karp I, Pineau CA. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. J. Rheumatol.32, 820–823 (2005).
   PubMedGoogle Scholar
• Egner W. The use of laboratory tests in the diagnosis of SLE. J. Clin. Pathol.53, 424–432 (2000).
   PubMed Web of Science ®Google Scholar
• Eissfeller P, Sticherling M, Scholz D et al. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann. NY Acad. Sci.1050, 327–339 (2005).
   PubMedGoogle Scholar
• McCauliffe DP. Cutaneous diseases in adults associated with anti-Ro/SS-A autoantibody production. Lupus6, 158–166 (1997).
   PubMedGoogle Scholar
• Fonseca E, Alvarez R, Gonzalez MR, Pascual D. Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus. Lupus1, 265–268 (1992).
   PubMedGoogle Scholar
• Ackerman AB. Lupus erythematosus. In: Histologic Diagnosis of Inflammatory Skin Diseases (2nd Edition). Ackerman AB (Ed.). Williams & Wilkins, Baltimore, MD, USA 525–546 (1997).
   Google Scholar
• George R, Kurian S, Jacob M, Thomas K. Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int. J. Dermatol.34, 170–173 (1995).
   Google Scholar
• Cardinali C, Caproni M, Fabbri P. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Clin. Exp. Rheumatol.17, 427–432 (1999).
   Google Scholar
• Magro CM, Crowson AN, Harrist TJ. The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br. J. Dermatol.134, 855–862 (1996).
   PubMedGoogle Scholar
• Zecevic RD, Pavlovic D, Stefanovic D. Lupus band test and disease activity in systemic lupus erythematosus: does it still matter? Clin. Exp. Dermatol.31, 358–360 (2006).
   PubMed Web of Science ®Google Scholar
• Sticherling M. Ciclosporin bei Kollagenosen. In : Ciclosporin in der Dermatologie Georg Thieme Verlag, Stuttgart, Germany (2003).
   Google Scholar